Showing results (161-170 of 182) with videos related to
Sort By:
Pageof 19
Clinical Therapeutics|September 1, 2004
A randomized, double-blind, parallel-group comparison of controlled- and immediate-release oxybutynin chloride in urge urinary incontinenceJack Barkin, Jacques Corcos, Sidney Radomski, et al.Neurourology and Urodynamics|July 27, 2017
Long-term outcomes and risks factors for failure of intradetrusor onabotulinumtoxin A injections for the treatment of refractory neurogenic detrusor overactivityCharles Joussain, Mélanie Popoff, Véronique Phé, et al.BJU International|June 26, 2004
Complications of tension-free vaginal tape surgery: a multi-institutional reviewRobert Abouassaly, Jordan R Steinberg, Marguerite Lemieux, et al.The Journal of Urology|June 11, 2005
Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month studyBrigitte Schurch, Marianne de Sèze, Pierre Denys, et al.Journal of the American Geriatrics Society|January 9, 2008
Creation and testing of the Geriatric Self-Efficacy Index for Urinary IncontinenceCara Tannenbaum, Judith Brouillette, Nicol Korner-Bitensky, et al.The Prostate|April 29, 2009
Botulinum toxin type A inhibits the growth of LNCaP human prostate cancer cells in vitro and in vivoGilles Karsenty, Joice Rocha, Simone Chevalier, et al.The Journal of Urology|April 19, 2011
Efficacy of botulinum toxin A injection for neurogenic detrusor overactivity and urinary incontinence: a randomized, double-blind trialSender Herschorn, Jerzy Gajewski, Karen Ethans, et al.Neurourology and Urodynamics|May 18, 2019
Alpha-blockers for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: A systematic review and meta-analysis. A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS)Marc P Schneider, Jure Tornic, Radek Sýkora, et al.Journal of the American Geriatrics Society|February 4, 2009
Responsiveness and clinical utility of the geriatric self-efficacy index for urinary incontinenceCara Tannenbaum, Judith Brouillette, Julie Michaud, et al.European Urology|March 26, 2004
European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivityAndré Reitz, Manfred Stöhrer, Guus Kramer, et al.Pageof 19